Digestion (normal) |
|
|
Clinical Trial: Prevention of Postoperative Delirium with Donepezil
This study is not yet open for patient recruitment.
Verified by Technische Universität München September 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Cognitively normal elderly individuals | Drug: Donepezil | Phase IV |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Secondary Outcomes: Cognitive performance
Expected Total Enrollment: 300
Study start: January 2006; Expected completion: May 2008
Last follow-up: December 2007; Data entry closure: February 2008
Eligibility
Inclusion Criteria:
- Cognitively healthy, elective hip or knee replacement
Exclusion Criteria:
- Ongoing cholinergic treatment, dementia, delirium, acute physical illness
Location and Contact Information
Germany
Deps. of Psychiatry and Anaesthesiology, Tech. Universitaet Munich, Munich, D-81675, Germany
Janine Diehl, M. D., Principal Investigator
Janine Diehl, M. D., Principal Investigator, Dept. of Psychiatry, Technische Universitaet Muenchen
More Information
Last Updated: September 21, 2005
Record first received: September 14, 2005
ClinicalTrials.gov Identifier: NCT00220896
Health Authority: Germany: Federal Institute for Drugs and Medicinal Devices
ClinicalTrials.gov processed this record on 2005-09-27
Resources
- Your Digestive System and How It Works (National Institute of Diabetes and Digestive and Kidney Diseases)

Not Signed In -

